Phase I-II trial of twice-weekly gemcitabine and concomitant irradiation in patients undergoing pancreaticoduodenectomy with extended lymphadenectomy for locally advanced pancreatic cancer

Define the maximum tolerated dose (MTD), tolerability, and efficacy of gemcitabine given concomitantly with radiotherapy in patients with locally advanced pancreatic cancer. Patients were required to have locally advanced T1–T3 resectable pancreatic cancer. Gemcitabine, given twice weekly before irr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of radiation oncology, biology, physics biology, physics, 2004-10, Vol.60 (2), p.444-452
Hauptverfasser: Joensuu, Timo K., Kiviluoto, Tuula, Kärkkäinen, Päivi, Vento, Pälvi, Kivisaari, Leena, Tenhunen, Mikko, Westberg, Ronny, Elomaa, Inkeri
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!